Please login to the form below

Not currently logged in
Email:
Password:

severe hypertriglyceridemia

This page shows the latest severe hypertriglyceridemia news and features for those working in and with pharma, biotech and healthcare.

AZ target Omthera files blood fat drug in US

AZ target Omthera files blood fat drug in US. FDA submission for Epanova in severe hypertriglyceridemia. ... The company, which is the subject of a $443m takeover by AstraZeneca (AZ), filed the drug with the Food and Drug Administration (FDA) for use in

Latest news

  • AstraZeneca offers $443m to buy Omthera AstraZeneca offers $443m to buy Omthera

    In trials, the product has been shown to reduce triglyceride levels and improve other blood lipid profiles and is due to be filed for approval for severe hypertriglyceridemia in the coming

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics